| scholarly article | Q13442814 |
| P2093 | author name string | Haibo Wang | |
| M Elizabeth Hartnett | |||
| Yanchao Jiang | |||
| Grace Byfield | |||
| George Wesley Smith | |||
| Manabu McCloskey | |||
| P2860 | cites work | Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. | Q30844301 |
| Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model | Q33347690 | ||
| Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy | Q33379554 | ||
| Clinical implications of vascular growth factors in proliferative retinopathies | Q33575962 | ||
| Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins | Q33775844 | ||
| Organogenesis and tumorigenesis: Insight from the JAK/STAT pathway in the Drosophila eye | Q34275385 | ||
| The JAK/STAT signaling pathway | Q34305849 | ||
| Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy | Q34324536 | ||
| Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor | Q34379342 | ||
| HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin | Q34775400 | ||
| Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. | Q35085027 | ||
| VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. | Q35688115 | ||
| Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy | Q35688128 | ||
| The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years | Q35762664 | ||
| IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. | Q35973404 | ||
| IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development | Q35973411 | ||
| Erythropoietin deficiency decreases vascular stability in mice. | Q36404124 | ||
| Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model | Q36618068 | ||
| Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease | Q36761991 | ||
| Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy | Q37018797 | ||
| Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity | Q37405102 | ||
| A review of clinical trials of anti-VEGF agents for diabetic retinopathy | Q37696351 | ||
| The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity | Q39756440 | ||
| Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways | Q40399370 | ||
| Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia | Q40935597 | ||
| Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia | Q41677354 | ||
| Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. | Q41829449 | ||
| The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model | Q42155684 | ||
| Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. | Q42577163 | ||
| Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity | Q42942158 | ||
| VEGF differentially activates STAT3 in microvascular endothelial cells | Q44489900 | ||
| Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli | Q44695731 | ||
| Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity | Q47195793 | ||
| Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation | Q47745076 | ||
| Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow. | Q48033511 | ||
| Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm | Q48206315 | ||
| Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants | Q48447815 | ||
| Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. | Q53260323 | ||
| Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. | Q53793126 | ||
| Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy | Q58207697 | ||
| Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group | Q70571517 | ||
| Transcutaneous oxygen levels in retinopathy of prematurity | Q71567090 | ||
| Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization | Q72120451 | ||
| The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis | Q72298016 | ||
| Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat | Q72650581 | ||
| Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity | Q73298393 | ||
| Genetic susceptibility to retinopathy of prematurity | Q79322970 | ||
| Retinopathy of prematurity | Q79858093 | ||
| Differential role of Jak-STAT signaling in retinal degenerations | Q80243609 | ||
| Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor | Q82129963 | ||
| [Retinopathy of prematurity and oxidative stress] | Q82776670 | ||
| Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity | Q83296386 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythropoietin | Q218706 |
| P304 | page(s) | 1243-1253 | |
| P577 | publication date | 2012-01-09 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression | |
| P478 | volume | 180 |
| Q38282728 | A positive feedback loop between prolactin and STAT5 promotes angiogenesis |
| Q52688316 | Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Müller cells. |
| Q36752978 | Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity |
| Q36379513 | Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy |
| Q42548814 | Assessment of vascular regeneration in the CNS using the mouse retina |
| Q55262530 | Clinical and prognostic significance of signal transducer and activator of transcription 3 and mucin 1 in patients with non-small cell lung cancer following surgery. |
| Q42379900 | Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis |
| Q48120672 | Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization. |
| Q47806649 | Erythropoietin in diabetic retinopathy. |
| Q88581163 | Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy |
| Q90482902 | Histone demethylase KDM4C activates HIF1α/VEGFA signaling through the costimulatory factor STAT3 in NSCLC |
| Q36355485 | Hypoxia-induced oxidative stress in ischemic retinopathy |
| Q50926952 | Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients. |
| Q39224184 | Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor |
| Q47758114 | Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human |
| Q38069895 | Mechanisms and management of retinopathy of prematurity |
| Q42219273 | Metabolic adaptation and neuroprotection differ in the retina and choroid in a piglet model of acute postnatal hypoxia |
| Q38274655 | Pathophysiology and mechanisms of severe retinopathy of prematurity |
| Q36925591 | Proline-rich tyrosine kinase 2 via enhancing signal transducer and activator of transcription 3-dependent cJun expression mediates retinal neovascularization |
| Q37640165 | Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birth |
| Q37561227 | Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity |
| Q35925825 | STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin |
| Q37404757 | STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells |
| Q37149035 | Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity |
| Q42081421 | Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity |
| Q47828029 | Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms. |
| Q37577214 | Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity |
| Q38560836 | VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis |
Search more.